NCT05418582 - Drug-drug Interactions Between DZD9008 and Itraconazole/Carbamazepine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

June 1, 2022

Study Completion Date

December 8, 2022

Conditions

Healthy Subjects

Interventions

DRUG

DZD9008 and intraconazole

All subjects will receive DZD9008 single dose on Day 1, and the second dose of DZD9008 along with itraconazole after the wash-out period.

DRUG

DZD9008 and carbamazepine

All subjects will receive DZD9008 single dose on Day 1, and the second dose of DZD9008 along with carbamazepine after the wash-out period.

Trial Locations (1)

Pharmaceutical Research Associates, Inc., Lenexa